US 6,150,384 AGranted

Pharmaceutical composition

AssigneeTakeda Chemical Industries, Ltd.

InventorsHitoshi Ikeda, Takashi Sohda, Hiroyuki Odaka

Life of this patent

Estimating the term…

Abstract

Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.

Claims17

Dependent claims

A method for treating lipid metabolism disorders in a mammal in need thereof, which comprises administering to such mammal a therapeutically effective amount of an insulin sensitivity enhancer in combination with a biguanide.

Dependencies are inferred from the claim text.

Facts

Application: 09/303,493Filed 30 Apr 1999 · division
Priority: JP 7-15350020 Jun 1995
Granted: 21 Nov 2000
Term ends: Not estimatedThe source records don’t support an estimate.

Classification28 codes

A61K 9/2018
Organic compounds, e.g. phospholipids, fats: sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
A61K 9/2054
Polysaccharides, e.g. alginate, gums; Cyclodextrin: cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
A61K 9/4858
Filling excipients; Inactive ingredients: organic compounds
A61K 31/135
Amines: having aromatic rings , e.g. ketamine, nortriptyline

Family

Serial667,979Parent of this division · filed 19 Jun 1996
Serial057,465Parent of this division · filed 9 Apr 1998
US 5,965,584 AParent of this division
US 5,952,356 AParent of this division
US 6,150,384 AThis patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results